Resultados de la búsqueda 1121-1130 of 4198 for AM - PM
... p.m. CDT; New study finds triple-negative breast cancer tumors with an ... 04, 2023, 11:00 a.m. CDT; Beyond BRCA1/2: Pinpointing the risk of inherited breast ...
https://www.rheumatology.org/I-Am-A/Patient-Caregiver/Treatments/Cyclophosphamide-Cytoxan. ... 20, 2024, 04:55 p.m. CDT; Hepatic artery infusion pump therapy for ...
The purpose of phase 1 of this trial is to determine the maximum tolerated dose of temozolomide followed by selinexor in recurrent glioblastoma patients as ...
The purpose of this study is to find out more about certain markers of immune suppression in people with kidney tumors (whether the tumors are benign or cancer) ...
... p.m. CDT; Mayo Clinic surgeon: Living kidney ... a.m. CDT; Mayo Clinic Minute: What is a living ... p.m. CDT; Transforming Transplant Initiative aspires ...
The primary objectives are to determine the maximum tolerated dose (MTD) or highest protocol-defined dose (HPDD); in the absence of exceeding the MTD of ...
Immunotoxins, such as inotuzumab ozogamicin, are antibodies linked to a toxic substance and may help find cancer cells that express CD22 and kill them without ...
... p.m. CDT; Mayo Clinic-trained transplant surgeon ... a.m. CDT; Mayo Clinic Minute: What is a living ... p.m. CDT; Transforming Transplant Initiative ...
The purpose of this study is to do data collection of EEG findings to determine whether new types analysis of intracranial EEG can add different and ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?